Health

Regeneron starts Phase 3 trial of Covid antibody drug that might treat and prevent infection, company says

An antibody cocktail is now beginning late-stage clinical trials to evaluate the drug's ability to prevent and treat coronavirus infection. The biotechnology company Regeneron announced the late-stage clinical trials of REGN-COV2, its investigational double antibody cocktail for the treatment and…